Dermatology Pathways
7 pathways
- Suspicious Pigmented Lesion — Melanoma PathwayABCDE assessment, 2WW referral, and Breslow thickness staging for melanomaNICE NG14 2015 / BAD
- Cellulitis and ErysipelasEron class severity grading, IV vs oral antibiotic decision, and marking for monitoringNICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up TherapyPASI/DLQI-based severity classification and topical to biologic treatment escalation for plaque psoriasisNICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up TherapyIGA-based severity assessment and NICE step-up treatment ladder for atopic eczema in adults and childrenNICE NG95 2023
- Urticaria and AngioedemaAcute vs chronic urticaria classification, anaphylaxis exclusion, and antihistamine step-up managementBSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and TreatmentSeverity grading and NICE-aligned topical to systemic to isotretinoin treatment escalationNICE NG198 2021 / BAD
- Non-Melanoma Skin Cancer — BCC and SCCBCC vs SCC recognition, risk stratification, 2WW referral criteria, and treatment optionsNICE NG12 2015 / BAD NMSC Guidelines